Navigation Links
Recent Research Holds Wealth of Promise to Bone Marrow Patients

Australian researchers seem to have made headway in the development of an investigative blood test that could recognize the vulnerability of patients to develop complications in the bone marrow, leading to life threatening difficulties.

A conjoined effort between Brisbane's Mater Medical Research Institute (MMRI) and Sydney's West mead Hospital Bone Marrow Transplant Unit has resulted in a simple blood test to detect such tendencies.

Researchers have produced an antibody created from immunized mouse cells that effectively keeps a check on white blood cells, called dendritic cells. These cells are behind the occurrence of graft versus host disease (GVHD) - where donor cells destroy the patients cells.

GVHD negatively impacts the life of nearly 85 per cent of bone marrow transplant patients and kills almost 15 per cent. Sufferers may face acute skin infections, severe abdominal pain, and liver failure.

This antibody developed by researchers will enable a warning to doctors when dendritic cells just about begin their destruction activity. This will allow for treatment to commence much earlier, than later, giving a chance for better treatment outcomes.

MMRI director Professor Derek Hart said,"Think of it as a big fire inside the patient - it's much easier to put out a small fire than a large fire. The excitement is that if you can start much earlier you could switch it off with less use of drugs, with fewer problems and stop the fire gaining hold."

Prof Hart explained the present treatment which involved giving drugs after the onset of infection; but it would greatly help if it is treated before the onset, so that the immune system is not greatly affected. Further testing and research of this new method is required before it can be employed, researchers said.


'"/>




Page: 1

Related medicine news :

1. Recent Study On Rats May Lead To Future Robotics
2. Novel Strain Detected In The Recent Outbreak Of Bird Flu At Ukraine
3. Recent Poultry Deaths Rocks Romania
4. Dogs Were Domesticated Recently Only
5. Recently discovered deep-sea reefs catch the attention of the drug discovery team
6. Enbrelr Enters Safer Zone After Recent Research
7. Stress Could Kill Brain Cells, Says a Recent Study
8. Recent Research Holds Wealth of Promise to Bone Marrow Patients
9. Kidney Stones - Interesting New Research implicates bacteria as its cause
10. Researchers urge caution in using ear tube surgery
11. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/22/2017)... ... August 22, 2017 , ... TopConsumerReviews.com recently gave a ... fight Fatigue . , As the stress of modern life continually makes more demands ... Constant use of artificial stimulants can trap people in vicious high/low cycles and can ...
(Date:8/22/2017)... ... 22, 2017 , ... Although Labor Day is not as popular for fireworks ... weekend displays, and numerous households celebrate the unofficial end of summer with backyard fireworks ... pets. , Kris Zambo, owner of Dynamite Fireworks in Hammond, Indiana, ...
(Date:8/21/2017)... ... August 22, 2017 , ... ... risk to health and safety. By learning and implementing best practices for containment ... In this webinar, attendees will gain a better understanding of a method for ...
(Date:8/21/2017)... (PRWEB) , ... August 21, 2017 , ... ... the addition of two plastic surgery fellows for academic year 2017-2018, Christina M. ... candidates who have successfully completed residency in Plastic and Reconstructive Surgery. The ...
(Date:8/21/2017)... ... August 21, 2017 , ... SportsEngine, Inc. , ... Official Technology Partner of North Country Region Volleyball and will power registration, scheduling, ... along with providing sport management software to their member clubs. , ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017  Axium Pharmaceuticals Inc., the creator of ... to be in the beginning stages of an IPO. ... epilepsy medications with the average cost of a prescription epilepsy drug being ... AXIUM ... Another staggering figure is the fact that ...
(Date:8/14/2017)... N.J. and PETACH TIKVAH, Israel ... Inc. (NASDAQ: BCLI), a leading developer of adult stem ... the second quarter ending June 30, 2017. ... stages of preparing for our pivotal Phase 3 trial ... Chaim Lebovits , President and Chief Executive Officer of ...
(Date:8/8/2017)... 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage biopharmaceutical ... financial results for the second quarter ended June 30, ... quarter 2017 and to date: ... for the Company,s lead project, BL-8040: ... BL-8040 as novel stem cell mobilization treatment for autologous ...
Breaking Medicine Technology: